Nordea Investment Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Buy |
704,377
+564,537
| +404% | +$2.95M | ﹤0.01% | 619 |
|
|
2025
Q1 | $891K | Buy |
139,840
+3,353
| +2% | +$21.4K | ﹤0.01% | 823 |
|
|
2024
Q4 | $1M | Sell |
136,487
-286,600
| -68% | -$2.11M | ﹤0.01% | 806 |
|
|
2024
Q3 | $3.24M | Buy |
423,087
+147,552
| +54% | +$1.13M | ﹤0.01% | 603 |
|
|
2024
Q2 | $2.43M | Buy |
275,535
+39,871
| +17% | +$352K | ﹤0.01% | 664 |
|
|
2024
Q1 | $2.41M | Buy |
235,664
+87,190
| +59% | +$891K | ﹤0.01% | 683 |
|
|
2023
Q4 | $1.5M | Sell |
148,474
-2,687
| -2% | -$27.2K | ﹤0.01% | 747 |
|
|
2023
Q3 | $1.42M | Sell |
151,161
-1,516
| -1% | -$14.3K | ﹤0.01% | 751 |
|
|
2023
Q2 | $3.78M | Buy |
152,677
+3,415
| +2% | +$84.5K | 0.01% | 575 |
|
|
2023
Q1 | $3.45M | Sell |
149,262
-4,833
| -3% | -$112K | 0.01% | 595 |
|
|
2022
Q4 | $3.84M | Buy |
154,095
+635
| +0.4% | +$15.8K | 0.01% | 570 |
|
|
2022
Q3 | $2.98M | Sell |
153,460
-558
| -0.4% | -$10.8K | ﹤0.01% | 620 |
|
|
2022
Q2 | $3.91M | Buy |
154,018
+2,483
| +2% | +$63.1K | 0.01% | 587 |
|
|
2022
Q1 | $3.99M | Buy |
151,535
+2,510
| +2% | +$66.1K | 0.01% | 621 |
|
|
2021
Q4 | $6.21M | Buy |
149,025
+139,722
| +1,502% | +$5.83M | 0.01% | 541 |
|
|
2021
Q3 | $414K | Buy |
+9,303
| New | +$414K | ﹤0.01% | 943 |
|